Company profile: hVIVO
1.1 - Company Overview
Company description
- Provider of niche CRO pharmaceutical services specializing in human challenge clinical trials to test vaccines and antivirals for infectious and respiratory diseases, operating Europeβs only 24-bedroom quarantine clinic with onsite virology. Offers clinical trial design and execution, lab assays, and tech-enabled volunteer recruitment (including FluCamp), alongside ESG initiatives.
Products and services
- Human Challenge Clinical Trials: Engineers clinical-grade studies exposing volunteers to infectious and respiratory pathogens to evaluate vaccines and antivirals, using Europe's only 24-bedroom quarantine clinic with onsite virology, isolated rooms
- Venn Life Sciences Capability: Architects modular drug development consultancy, clinical trial design, and execution services for infectious and respiratory disease investigations
- FluCamp Clinical Trials Recruitment: Delivers controlled-environment volunteer recruitment for clinical trials targeting infectious and respiratory diseases, identifying and enrolling participants to take part under supervised conditions
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to hVIVO
Evergreen Theragnostics
HQ: United States
Website
- Description: Provider of radiopharmaceutical contract development and manufacturing services, covering early-stage development through commercial production. The company develops and commercializes radiopharmaceuticals (e.g., Ga-68 DOTATOC), discovers novel radiopharmaceuticals for unmet clinical needs in cancer treatment, and operates an Alpha Therapy Line for GMP Ac-225 products and a Springfield facility compliant with US FDA 21 CFR 211 and EMA cGMP.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Evergreen Theragnostics company profile β
Amofor
HQ: Germany
Website
- Description: Provider of formulation development for active ingredients in pharmaceutical, agrochemical, and life science applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Amofor company profile β
Nexelis
HQ: United States
Website
- Description: Provider of assay development and advanced laboratory testing; a portfolio company of Ampersand Capital Partners.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Nexelis company profile β
McKesson
HQ: United States
Website
- Description: Provider of pharmaceutical distribution (branded, generic, OTC) to healthcare providers; wholesale medical supplies and equipment; pharmacy management tools and consulting; specialty practice solutions including value-based care, group purchasing, and EHR; biopharma commercialization, medication access and adherence programs; and biosimilars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full McKesson company profile β
Safety Partners
HQ: United States
Website
- Description: Provider of environmental, health, safety, and regulatory compliance services, including permit and license management, EHS program development and implementation, industrial hygiene, animal care and use support for vivarium setup and compliance, web-based and on-site training, and lab relocation and decommissioning, including permit transfers and decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Safety Partners company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for hVIVO
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to hVIVO
2.2 - Growth funds investing in similar companies to hVIVO
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for hVIVO
4.2 - Public trading comparable groups for hVIVO
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β